Exploring the Interplay Between Gut Microbiota, Inflammatory Pathways, and Osteoarthritis: The “Gut-Joint” axis and Implications for Therapeutic Development
Ecem Kilic Background: Osteoarthritis (OA) is a degenerative joint disease affecting approximately 300 million individuals globally,1 with its prevalence increasing 113% since 19902. Pathological changes encompass cartilage and bone degradation, osteophyte formation, and synovial membrane inflammation. While biomechanical factors are well-known contributors, there is a growing recognition of systemic influences,…